Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 28, 2017
Patent Application Number
14764402
Date Filed
January 29, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are compounds having enhanced potency in the modulation of NMD A receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
